Clinical Trial Update: Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports on combining a monoclonal antibody therapy with Bacillus Calmette-Guérin for limited-stage small cell lung cancer; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)
• Monoclonal antibody therapy

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED